Synthetic Genomics (SGI) and the J. Craig Venter Institute (JCVI) have formed a new company, Synthetic Genomics Vaccines (SGVI), to develop next - generation vaccines based
on synthetic genome technology.
Not exact matches
Synthetic biology enables researchers to tackle a huge and diverse range of applied problems: building a cell with the smallest possible
genome; synthesizing proteins with extra amino acids — more than the 20 found in nature; using bacteria to produce medicines previously too complex to synthesize; even decomposing living organisms into standard, off - the - shelf «biobricks» that can be assembled
on demand.
We do not have the computing power
on the planet to make a
synthetic human
genome.
Craig Venter and his teams at the J. Craig Venter Institute in Rockville, Maryland, and San Diego, California, have shown themselves to be technical wizards by synthesising a
genome from code contained
on a computer, and using it to start a cell line of the resulting
synthetic organism (see «How the
synthetic bacterium was made»).
Synthetic biologists are fitting the genomes of microorganisms with synthetic gene circuits to break down polluting plastics, non-invasively diagnose and treat infections in the human gut, and generate chemicals and nutrition on long - haul space
Synthetic biologists are fitting the
genomes of microorganisms with
synthetic gene circuits to break down polluting plastics, non-invasively diagnose and treat infections in the human gut, and generate chemicals and nutrition on long - haul space
synthetic gene circuits to break down polluting plastics, non-invasively diagnose and treat infections in the human gut, and generate chemicals and nutrition
on long - haul space flights.
Moreover; advances in
genome engineering through CRISPR / Cas9 technology will provide an effective platform
on which to perform large - scale screens and identify new
synthetic lethal partners.
In 2012 he founded and is now Co-Director of the Concordia Centre for Applied
Synthetic Biology, Canada's only research centre focused on synthetic biology, also home to The Genome Foundry, a unique technology platform that aspires to accelerate the design - build - test cycle of biological eng
Synthetic Biology, Canada's only research centre focused
on synthetic biology, also home to The Genome Foundry, a unique technology platform that aspires to accelerate the design - build - test cycle of biological eng
synthetic biology, also home to The
Genome Foundry, a unique technology platform that aspires to accelerate the design - build - test cycle of biological engineering.
The JCVI teams are focused
on a variety of genomic research areas including continued work in
synthetic biology; sampling and analysis of the world's oceans, fresh water and soils to better understand the microbes living in these environments; and new analysis
on the human
genome in the hopes of discovering new insights into disease prevention and treatment.
On May 20th of this year, researchers at the J.C. Venter Institute announced the creation of a bacterial cell controlled by a synthesized
genome, a significant milestone in the emerging field of
synthetic biology.
New bioterrorism concerns, patent issues, and corporate monopolies
on genomes all cast long shadows over the potential of
synthetic biology.